INCY News and Press, Incyte Corporation From 03/22/23

2023-03-22 14:09:27 ET Incyte ( NASDAQ: INCY ) announced Wednesday that the FDA cleared its intravenous PD-1 inhibitor Zynyz under the agency’s accelerated approval program for patients with Merkel cell carcinoma (MCC), a rare form of skin cancer. The agency has use...

— First regulatory approval for Incyte PD-1 inhibitor based on the results of the POD1UM-201 trial — Zynyz is also being studied in additional tumor types and in combination with other Incyte pipeline compounds Incyte (Nasdaq:INCY) today announced that the U.S. F...

2023-03-20 08:07:19 ET Incyte ( NASDAQ: INCY ) shares traded ~5% higher on Monday after announcing that its oral JAK1 inhibitor povorcitinib met the primary endpoint in a Phase 2b clinical trial for adults with vitiligo, a chronic autoimmune disease characterized by skin dep...

- Patients treated with povorcitinib experienced improvements in total body and facial repigmentation; investigational therapy was well tolerated - Results were featured as an oral presentation in a late-breaking abstract session at the 2023 American Academy of Dermatology (AAD) Annual ...

- Patients achieving a high level of facial repigmentation (≥F-VASI90) at Week 52 maintained durable response one year following withdrawal of treatment - Continued treatment with Opzelura for up to two years resulted in sustained facial repigmentation and further improvements in...

2023-03-17 15:00:22 ET Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calenda...

2023-03-16 06:31:14 ET Summary The pharma/biotech subsector is undervalued by 16% relative to 11-year averages. Healthcare equipment is the less attractive subsector regarding both valuation and quality. Fast facts on PBE, a biotechnology and genomics ETF. 10 stocks cheape...

2023-03-10 15:00:56 ET Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calenda...

2023-03-08 06:41:29 ET Fed Chairman Jerome Powell undercut pivot expectations and dented stocks and bonds in his recent Congressional testimony. The S&P 500 ( SP500 ) ( NYSEARCA: SPY ), Nasdaq ( COMP.IND ), Nasdaq 100 ( NDX ) ( QQQ ) and Dow ( DJI ...

2023-03-07 07:03:02 ET Caris Life Sciences (Caris) announces a strategic research partnership with Incyte ( NASDAQ: INCY ) to augment precision medicine approaches for Incyte's oncology pipeline. The partnership will apply Caris' data and analytics tools, comprehe...